Clinical trial Recruiting at 2 sites Observational Ages 18 to 45 Women only

Assessing placental health in pregnancies with growth restriction

Official title: MRI Assessment of Placental Health

Run by Boston Children's Hospital · NCT02297724 · Data updated 2026-11-12

This study is trying to find better ways to decide when to deliver babies at risk of stillbirth due to growth issues by looking at how well the placenta is working in pregnant women with these conditions.

More Intrauterine Growth Restriction trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment80 (estimated)
SponsorBoston Children's Hospital
Academic / other
Locations2 sites (Boston, Massachusetts and 1 other locations)
StatusRecruiting
StartedApril 2014
Main results expectedSeptember 2027
Study endsSeptember 2028
Registry record updatedDecember 12, 2025
Trial IDNCT02297724 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pregnant women aged 18 to 45 with singleton or twin gestations diagnosed with IUGR based on specific ultrasound criteria.

Probably not a fit

Patients with fetuses that have chromosomal anomalies will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop methods for informed decision-making regarding the delivery timing of fetuses at increased risk of stillbirth due to intrauterine growth restriction (IUGR). It focuses on characterizing placental health by assessing the efficiency of oxygen transport, which is crucial for fetal development. The study involves pregnant mothers with either twin or singleton gestations diagnosed with IUGR based on ultrasound findings. By evaluating placental pathologies and their impact on maternal-fetal exchange, the researchers hope to improve outcomes for affected pregnancies.

Why it matters

Potential benefit: If successful, this study could lead to better management strategies for pregnancies affected by IUGR, potentially reducing the risk of stillbirth.

How similar studies have gone: Other studies have explored placental health in relation to IUGR, but this specific approach to assessing oxygen transport efficiency is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. The pregnant mother with twin gestation with diagnosis of selective IUGR based upon obstetrical US findings as following:

   * Proven monochorionicity / dichorionicity
   * Discordance in estimated fetal weight (EFW). Growth restriction (\<10 percentile of norm) in one or both fetus(es) AND/OR growth discordance (\> or = 20%) between twin fetuses.
2. The pregnant mother with singleton gestation with diagnosis of IUGR based upon obstetrical US findings as following:

   * Proven singleton gestation
   * Growth restriction of fetus (\<10 percentile of norm)
   * Doppler measurements that indicates placental insufficiency: umbilical artery, middle cerebral artery, uterine artery; or oligohydramnios.
3. Gestational age: Bigger than 18 weeks.
4. Pregnant mother is between age 18 to 45, clinically stable and can safely tolerate fetal MRI study.

Exclusion Criteria:

Fetuses/infants with the following features will be excluded.

1. Fetus/infant with chromosomal anomalies or known genetic disorders.
2. Fetus/infant with other major congenital malformation.
3. Presence of any condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient, quality or completeness of the data.

Pregnant mothers with the following features will be excluded.

1. Mothers with contraindication to MRI (with pacemaker, metal in body, oversize).
2. Mothers with claustrophobia
3. Mothers medically unstable for the MRI study

Where it's running

  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Hospital Universitario de Fuenlabrada
    Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: Patricia E Grant, MD — Boston Children's Hospital

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.